A detailed history of Vestmark Advisory Solutions, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Vestmark Advisory Solutions, Inc. holds 8,499 shares of NVS stock, worth $835,876. This represents 0.04% of its overall portfolio holdings.

Number of Shares
8,499
Previous 11,901 28.59%
Holding current value
$835,876
Previous $1.27 Million 22.83%
% of portfolio
0.04%
Previous 0.06%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$106.13 - $120.89 $361,054 - $411,267
-3,402 Reduced 28.59%
8,499 $977,000
Q2 2024

Aug 12, 2024

SELL
$92.57 - $107.37 $389,812 - $452,135
-4,211 Reduced 26.14%
11,901 $1.27 Million
Q1 2024

May 15, 2024

SELL
$95.27 - $108.47 $71,833 - $81,786
-754 Reduced 4.47%
16,112 $1.56 Million
Q4 2023

Feb 06, 2024

BUY
$92.27 - $101.54 $218,310 - $240,243
2,366 Added 16.32%
16,866 $1.7 Million
Q3 2023

Nov 06, 2023

SELL
$94.73 - $105.13 $3.03 Million - $3.36 Million
-31,950 Reduced 68.78%
14,500 $1.48 Million
Q2 2023

Aug 07, 2023

SELL
$92.52 - $104.91 $308,184 - $349,455
-3,331 Reduced 6.69%
46,450 $4.69 Million
Q1 2023

May 09, 2023

BUY
$80.03 - $92.81 $7,682 - $8,909
96 Added 0.19%
49,781 $4.58 Million
Q4 2022

Jan 20, 2023

SELL
$75.55 - $92.52 $37,019 - $45,334
-490 Reduced 0.98%
49,685 $0
Q3 2022

Nov 03, 2022

BUY
$74.61 - $87.26 $1.13 Million - $1.32 Million
15,117 Added 43.12%
50,175 $3.81 Million
Q2 2022

Aug 04, 2022

SELL
$80.52 - $93.75 $134,951 - $157,125
-1,676 Reduced 4.56%
35,058 $2.96 Million
Q1 2022

Apr 27, 2022

BUY
$80.11 - $90.62 $445,251 - $503,665
5,558 Added 17.83%
36,734 $3.22 Million
Q4 2021

Jan 31, 2022

BUY
$79.7 - $88.13 $100,501 - $111,131
1,261 Added 4.22%
31,176 $2.73 Million
Q3 2021

Nov 15, 2021

BUY
$81.78 - $95.14 $159,307 - $185,332
1,948 Added 6.97%
29,915 $2.45 Million
Q2 2021

Aug 09, 2021

BUY
$85.24 - $94.15 $237,137 - $261,925
2,782 Added 11.05%
27,967 $2.55 Million
Q1 2021

May 10, 2021

SELL
$83.5 - $98.47 $215,096 - $253,658
-2,576 Reduced 9.28%
25,185 $2.15 Million
Q4 2020

Feb 04, 2021

SELL
$78.07 - $94.43 $426,886 - $516,343
-5,468 Reduced 16.46%
27,761 $2.62 Million
Q3 2020

Oct 19, 2020

SELL
$82.14 - $91.0 $55,444 - $61,425
-675 Reduced 1.99%
33,229 $2.89 Million
Q2 2020

Aug 13, 2020

SELL
$80.93 - $91.1 $24,764 - $27,876
-306 Reduced 0.89%
33,904 $2.96 Million
Q1 2020

May 06, 2020

SELL
$70.67 - $99.01 $9,187 - $12,871
-130 Reduced 0.38%
34,210 $2.82 Million
Q4 2019

Feb 14, 2020

BUY
$84.35 - $95.37 $236,348 - $267,226
2,802 Added 8.88%
34,340 $3.25 Million
Q3 2019

Nov 05, 2019

BUY
$85.54 - $94.26 $203,243 - $223,961
2,376 Added 8.15%
31,538 $2.74 Million
Q2 2019

Aug 20, 2019

BUY
$75.4 - $92.8 $173,797 - $213,904
2,305 Added 8.58%
29,162 $2.66 Million
Q1 2019

May 14, 2019

BUY
$75.32 - $86.15 $2.02 Million - $2.31 Million
26,857 New
26,857 $2.58 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Vestmark Advisory Solutions, Inc. Portfolio

Follow Vestmark Advisory Solutions, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestmark Advisory Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vestmark Advisory Solutions, Inc. with notifications on news.